SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16863500
Source:
http://linkedlifedata.com/resource/pubmed/id/16863500
Search
Subject
(
39
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0152171
,
umls-concept:C1145760
,
umls-concept:C1457887
,
umls-concept:C1882083
pubmed:issue
8
pubmed:dateCreated
2006-7-25
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16863500-16506350
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8111305
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Epoprostenol
,
http://linkedlifedata.com/resource/pubmed/chemical/treprostinil
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0277-0008
pubmed:author
pubmed-author:HeraldNicoleN
,
pubmed-author:LaliberteKevinK
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1203; discussion 1203-4
pubmed:meshHeading
pubmed-meshheading:16863500-Antihypertensive Agents
,
pubmed-meshheading:16863500-Drug Labeling
,
pubmed-meshheading:16863500-Epoprostenol
,
pubmed-meshheading:16863500-Humans
,
pubmed-meshheading:16863500-Hypertension, Pulmonary
,
pubmed-meshheading:16863500-Information Storage and Retrieval
,
pubmed-meshheading:16863500-Infusions, Intravenous
,
pubmed-meshheading:16863500-Severity of Illness Index
pubmed:year
2006
pubmed:articleTitle
Treprostinil for the treatment of pulmonary arterial hypertension in patients with New York Heart Association class II-IV symptoms.
pubmed:affiliation
United Therapeutics Corporation, Research Triangle Park, North Carolina 27709, USA.
pubmed:publicationType
Journal Article
,
Comment